Yvonne L Greenstreet's Insider Trades & SAST Disclosures
Yvonne L Greenstreet's most recent trade in Alnylam Pharmaceuticals Inc was a trade of 36,293 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Yvonne L Greenstreet.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 36,293 | 36,293 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 17,965 | 102,512 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 243.36 per share. | 03 Mar 2025 | 1,173 | 100,271 (0%) | 0% | 243.4 | 285,461 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 242.37 per share. | 03 Mar 2025 | 1,068 | 101,444 (0%) | 0% | 242.4 | 258,851 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 244.41 per share. | 03 Mar 2025 | 791 | 99,480 (0%) | 0% | 244.4 | 193,328 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 245.26 per share. | 03 Mar 2025 | 580 | 98,900 (0%) | 0% | 245.3 | 142,251 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 246.18 per share. | 03 Mar 2025 | 238 | 98,662 (0%) | 0% | 246.2 | 58,591 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 247.35 per share. | 03 Mar 2025 | 23 | 98,639 (0%) | 0% | 247.3 | 5,689 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 248.25 per share. | 03 Mar 2025 | 4 | 98,635 (0%) | 0% | 248.3 | 993 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 5,921 | 87,447 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 5,921 | 5,921 | - | - | Restricted Stock Units | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 242.44 per share. | 27 Feb 2025 | 1,093 | 85,201 (0%) | 0% | 242.4 | 264,987 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 241.51 per share. | 27 Feb 2025 | 461 | 86,294 (0%) | 0% | 241.5 | 111,336 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 243.23 per share. | 27 Feb 2025 | 440 | 84,761 (0%) | 0% | 243.2 | 107,021 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 240.32 per share. | 27 Feb 2025 | 284 | 86,755 (0%) | 0% | 240.3 | 68,251 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 244.11 per share. | 27 Feb 2025 | 214 | 84,547 (0%) | 0% | 244.1 | 52,240 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 236.51 per share. | 27 Feb 2025 | 158 | 87,289 (0%) | 0% | 236.5 | 37,369 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 239.18 per share. | 27 Feb 2025 | 127 | 87,039 (0%) | 0% | 239.2 | 30,376 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 238.33 per share. | 27 Feb 2025 | 123 | 87,166 (0%) | 0% | 238.3 | 29,315 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 3,859 | 82,739 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 253.37 per share. | 13 Feb 2025 | 300 | 82,168 (0%) | 0% | 253.4 | 76,011 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 252.50 per share. | 13 Feb 2025 | 271 | 82,468 (0%) | 0% | 252.5 | 68,428 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 254.35 per share. | 13 Feb 2025 | 201 | 81,967 (0%) | 0% | 254.3 | 51,124 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 256.29 per share. | 13 Feb 2025 | 98 | 81,784 (0%) | 0% | 256.3 | 25,116 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 255.56 per share. | 13 Feb 2025 | 85 | 81,882 (0%) | 0% | 255.6 | 21,723 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 258.07 per share. | 13 Feb 2025 | 59 | 81,678 (0%) | 0% | 258.1 | 15,226 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 257.51 per share. | 13 Feb 2025 | 47 | 81,737 (0%) | 0% | 257.5 | 12,103 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 261.45 per share. | 13 Feb 2025 | 47 | 81,572 (0%) | 0% | 261.4 | 12,288 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 260.58 per share. | 13 Feb 2025 | 38 | 81,619 (0%) | 0% | 260.6 | 9,902 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 264.88 per share. | 13 Feb 2025 | 25 | 81,526 (0%) | 0% | 264.9 | 6,622 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 259.71 per share. | 13 Feb 2025 | 21 | 81,657 (0%) | 0% | 259.7 | 5,454 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 263.33 per share. | 13 Feb 2025 | 21 | 81,551 (0%) | 0% | 263.3 | 5,530 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne Greenstreet L | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 10,658 | 84,099 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Greenstreet Yvonne L | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 251.42 per share. | 25 Nov 2024 | 2,933 | 79,180 (0%) | 0% | 251.4 | 737,415 | Common Stock |
| Alnylam Pharmaceuticals Inc | Greenstreet L Yvonne | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 250.68 per share. | 25 Nov 2024 | 1,131 | 82,113 (0%) | 0% | 250.7 | 283,519 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 249.60 per share. | 25 Nov 2024 | 762 | 83,244 (0%) | 0% | 249.6 | 190,195 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne Greenstreet L | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 252.27 per share. | 25 Nov 2024 | 300 | 78,880 (0%) | 0% | 252.3 | 75,681 | Common Stock |
| Alnylam Pharmaceuticals Inc | Greenstreet L Yvonne | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 247.77 per share. | 25 Nov 2024 | 93 | 84,006 (0%) | 0% | 247.8 | 23,043 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 280.00 per share. | 20 Aug 2024 | 15,000 | 73,441 (0%) | 0% | 280 | 4,200,000 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 85.00 per share. | 20 Aug 2024 | 15,000 | 88,441 (0%) | 0% | 85 | 1,275,000 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 15,000 | 2,352 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 270.00 per share. | 01 Aug 2024 | 15,148 | 73,441 (0%) | 0% | 270 | 4,089,960 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 85.00 per share. | 01 Aug 2024 | 15,148 | 88,589 (0%) | 0% | 85 | 1,287,580 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 15,148 | 17,352 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 261.00 per share. | 11 Jul 2024 | 7,093 | 73,441 (0%) | 0% | 261 | 1,851,273 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 16,953 | 88,835 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 229.93 per share. | 24 Jun 2024 | 1,572 | 84,579 (0%) | 0% | 229.9 | 361,450 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 229.06 per share. | 24 Jun 2024 | 1,374 | 86,151 (0%) | 0% | 229.1 | 314,728 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 232.54 per share. | 24 Jun 2024 | 1,119 | 82,949 (0%) | 0% | 232.5 | 260,212 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 234.66 per share. | 24 Jun 2024 | 957 | 81,397 (0%) | 0% | 234.7 | 224,570 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 235.19 per share. | 24 Jun 2024 | 863 | 80,534 (0%) | 0% | 235.2 | 202,969 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 228.30 per share. | 24 Jun 2024 | 666 | 87,525 (0%) | 0% | 228.3 | 152,048 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 233.53 per share. | 24 Jun 2024 | 595 | 82,354 (0%) | 0% | 233.5 | 138,950 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 231.59 per share. | 24 Jun 2024 | 511 | 84,068 (0%) | 0% | 231.6 | 118,342 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 221.71 per share. | 24 Jun 2024 | 308 | 88,527 (0%) | 0% | 221.7 | 68,287 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 226.82 per share. | 24 Jun 2024 | 177 | 88,191 (0%) | 0% | 226.8 | 40,147 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 225.55 per share. | 24 Jun 2024 | 93 | 88,368 (0%) | 0% | 225.5 | 20,976 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 224.17 per share. | 24 Jun 2024 | 66 | 88,461 (0%) | 0% | 224.2 | 14,795 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 46,394 | 46,394 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 23,754 | 71,882 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 5,921 | 11,842 | - | - | Restricted Stock Units | |
| Alnylam Pharmaceuticals Inc | L Greenstreet Yvonne | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 5,921 | 51,060 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | L Greenstreet Yvonne | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 154.54 per share. | 27 Feb 2024 | 1,259 | 49,801 (0%) | 0% | 154.5 | 194,566 | Common Stock |
| Alnylam Pharmaceuticals Inc | L Greenstreet Yvonne | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 155.45 per share. | 27 Feb 2024 | 993 | 48,808 (0%) | 0% | 155.5 | 154,362 | Common Stock |
| Alnylam Pharmaceuticals Inc | L Yvonne Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 156.38 per share. | 27 Feb 2024 | 588 | 48,220 (0%) | 0% | 156.4 | 91,951 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 157.30 per share. | 27 Feb 2024 | 84 | 48,136 (0%) | 0% | 157.3 | 13,213 | Common Stock |
| Alnylam Pharmaceuticals Inc | L Greenstreet Yvonne | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 158.12 per share. | 27 Feb 2024 | 8 | 48,128 (0%) | 0% | 158.1 | 1,265 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne Greenstreet L | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 16,953 | 52,169 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Greenstreet L Yvonne | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 148.24 per share. | 15 Feb 2024 | 3,614 | 45,979 (0%) | 0% | 148.2 | 535,739 | Common Stock |
| Alnylam Pharmaceuticals Inc | L Yvonne Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 147.50 per share. | 15 Feb 2024 | 2,576 | 49,593 (0%) | 0% | 147.5 | 379,960 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne Greenstreet L | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 149.03 per share. | 15 Feb 2024 | 840 | 45,139 (0%) | 0% | 149.0 | 125,185 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 5,082 | 35,414 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 3,859 | 39,273 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 185.54 per share. | 03 Aug 2023 | 1,869 | 36,633 (0%) | 0% | 185.5 | 346,774 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 186.39 per share. | 03 Aug 2023 | 1,107 | 35,526 (0%) | 0% | 186.4 | 206,334 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 184.70 per share. | 03 Aug 2023 | 771 | 38,502 (0%) | 0% | 184.7 | 142,404 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 189.31 per share. | 03 Aug 2023 | 192 | 35,216 (0%) | 0% | 189.3 | 36,348 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 187.37 per share. | 03 Aug 2023 | 101 | 35,425 (0%) | 0% | 187.4 | 18,924 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 188.41 per share. | 03 Aug 2023 | 17 | 35,408 (0%) | 0% | 188.4 | 3,203 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 16,952 | 37,947 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 194.94 per share. | 26 Apr 2023 | 3,225 | 31,196 (0%) | 0% | 194.9 | 628,682 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 193.93 per share. | 26 Apr 2023 | 2,898 | 34,421 (0%) | 0% | 193.9 | 562,009 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 193.18 per share. | 26 Apr 2023 | 628 | 37,319 (0%) | 0% | 193.2 | 121,317 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 197.08 per share. | 26 Apr 2023 | 533 | 30,332 (0%) | 0% | 197.1 | 105,044 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 195.65 per share. | 26 Apr 2023 | 331 | 30,865 (0%) | 0% | 195.6 | 64,760 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 36,775 | 36,775 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 17,763 | 17,763 | - | - | Restricted Stock Units | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 189.76 per share. | 03 Aug 2022 | 5,433 | 21,564 (0%) | 0% | 189.8 | 1,030,966 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 5,083 | 18,985 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 4,153 | 23,138 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 3,859 | 26,997 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.83 per share. | 03 Aug 2022 | 195 | 21,369 (0%) | 0% | 209.8 | 40,917 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.85 per share. | 03 Aug 2022 | 194 | 21,175 (0%) | 0% | 209.9 | 40,711 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.25 per share. | 03 Aug 2022 | 180 | 20,995 (0%) | 0% | 210.3 | 37,845 | Common Stock |
| Pacira BioSciences Inc | Yvonne L Greenstreet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 8,225 | 8,225 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Yvonne L Greenstreet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 1,160 | 13,247 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 31,747 | 31,747 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2021 | 5,417 | 16,440 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 189.13 per share. | 21 Dec 2021 | 2,415 | 14,025 (0%) | 0% | 189.1 | 456,749 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 186.55 per share. | 21 Dec 2021 | 122 | 13,902 (0%) | 0% | 186.5 | 22,759 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 191.00 per share. | 21 Dec 2021 | 1 | 14,024 (0%) | 0% | 191 | 191 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges